31-45 of 162
A Comparison of PROMs and How to Use Them in Clinical Practice for PAH
MinuteCE®A Comparison of PROMs and How to Use Them in Clinical Practice for PAH
What Challenges and Triumphs Do Patients Face While Living With PAH?
MinuteCE®What Challenges and Triumphs Do Patients Face While Living With PAH?
PROMs in Clinical Practice: Impacting Treatment Decisions
MinuteCE®PROMs in Clinical Practice: Impacting Treatment Decisions
PROMs: Role in Clinical Research and Contributions to PAH Patient Perspectives
MinuteCE®PROMs: Role in Clinical Research and Contributions to PAH Patient Perspectives
How Do Patient Experiences and PAH Perspectives Vary Across Regions and Cultures Worldwide?
MinuteCE®How Do Patient Experiences and PAH Perspectives Vary Across Regions and Cultures Worldwide?
Expert Perspectives on Nonsteroidal MRAs and Cardiorenal Protection
CME/CEExpert Perspectives on Nonsteroidal MRAs and Cardiorenal Protection
- advertisement
Innovative Approaches to Managing CKM Syndrome and HFmrEF/HFpEF
CME/CEInnovative Approaches to Managing CKM Syndrome and HFmrEF/HFpEF
Where Does This Patient Land? Making Sense of Risk and LDL-C Goals
MinuteCE®Where Does This Patient Land? Making Sense of Risk and LDL-C Goals
The Dose Matters: Optimizing Statin Intensity in ASCVD Management
MinuteCE®The Dose Matters: Optimizing Statin Intensity in ASCVD Management
Expanding Access: Alternative Models for Delivering Lipid-Lowering Therapy
MinuteCE®Expanding Access: Alternative Models for Delivering Lipid-Lowering Therapy
- advertisement
Statins and Safety: What the Data Say About Dementia, Cancer, and More
MinuteCE®Statins and Safety: What the Data Say About Dementia, Cancer, and More
Closing the Loop: Practical Strategies for Timely Lipid Panel Follow-Up
MinuteCE®Closing the Loop: Practical Strategies for Timely Lipid Panel Follow-Up
Target in Sight: Escalating Therapy to Reach LDL-C Goals
MinuteCE®Target in Sight: Escalating Therapy to Reach LDL-C Goals
